134 related articles for article (PubMed ID: 25098425)
1. High CD20+ background cells predict a favorable outcome in classical Hodgkin lymphoma and antagonize CD68+ macrophages.
Panico L; Tenneriello V; Ronconi F; Lepore M; Cantore N; Dell'Angelo AC; Ferbo L; Ferrara F
Leuk Lymphoma; 2015 Jun; 56(6):1636-42. PubMed ID: 25098425
[TBL] [Abstract][Full Text] [Related]
2. The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt.
Mohamed O; El Bastawisy A; Allahlobi N; Abdellateif MS; Zekri ARN; Shaarawy S; Korany Z; Mohanad M; Bahnassy AA
Diagn Pathol; 2020 Feb; 15(1):10. PubMed ID: 32019558
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma.
Panico L; Ronconi F; Lepore M; Tenneriello V; Cantore N; Dell'Angelo AC; Ferbo U; Ferrara F
Leuk Lymphoma; 2013 Nov; 54(11):2418-25. PubMed ID: 23432688
[TBL] [Abstract][Full Text] [Related]
4. CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma.
Klein JL; Nguyen TT; Bien-Willner GA; Chen L; Foyil KV; Bartlett NL; Duncavage EJ; Hassan A; Frater JL; Kreisel F
Am J Clin Pathol; 2014 Mar; 141(3):381-7. PubMed ID: 24515766
[TBL] [Abstract][Full Text] [Related]
5. CD68 staining correlates with the size of residual mass but not with survival in classical Hodgkin lymphoma.
Agur A; Amir G; Paltiel O; Klein M; Dann EJ; Goldschmidt H; Goldschmidt N
Leuk Lymphoma; 2015 May; 56(5):1315-9. PubMed ID: 25204373
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of lymphocyte/monocyte ratio in advanced Hodgkin lymphoma: correlation with International Prognostic Score and tumor associated macrophages.
Jakovic LR; Mihaljevic BS; Andjelic BM; Bogdanovic AD; Perunicic Jovanovic MD; Babic DD; Bumbasirevic VZ
Leuk Lymphoma; 2016 Aug; 57(8):1839-47. PubMed ID: 26727349
[TBL] [Abstract][Full Text] [Related]
7. CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma.
Kayal S; Mathur S; Karak AK; Kumar L; Sharma A; Bakhshi S; Raina V
Leuk Lymphoma; 2014 May; 55(5):1031-7. PubMed ID: 24067108
[TBL] [Abstract][Full Text] [Related]
8. The prognostic role of tumor-associated macrophages and dendritic cells in classic Hodgkin's lymphoma.
Abdou AG; Asaad NY; Loay I; Shabaan M; Badr N
J Environ Pathol Toxicol Oncol; 2013; 32(4):289-305. PubMed ID: 24579783
[TBL] [Abstract][Full Text] [Related]
9. The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages.
Koh YW; Kang HJ; Park C; Yoon DH; Kim S; Suh C; Go H; Kim JE; Kim CW; Huh J
Oncologist; 2012; 17(6):871-80. PubMed ID: 22588324
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of CD20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: a clinicopathologic study.
Elsayed AA; Asano N; Ohshima K; Izutsu K; Kinoshita T; Nakamura S
Pathol Int; 2014 Jul; 64(7):336-45. PubMed ID: 25047504
[TBL] [Abstract][Full Text] [Related]
11. Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome.
Greaves P; Clear A; Coutinho R; Wilson A; Matthews J; Owen A; Shanyinde M; Lister TA; Calaminici M; Gribben JG
J Clin Oncol; 2013 Jan; 31(2):256-62. PubMed ID: 23045593
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma.
Guo B; Cen H; Tan X; Ke Q
BMC Med; 2016 Oct; 14(1):159. PubMed ID: 27745550
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of CD20 expression in classical Hodgkin lymphoma: a clinicopathological study of 119 cases.
Tzankov A; Krugmann J; Fend F; Fischhofer M; Greil R; Dirnhofer S
Clin Cancer Res; 2003 Apr; 9(4):1381-6. PubMed ID: 12684408
[TBL] [Abstract][Full Text] [Related]
14. Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival.
Barros MH; Segges P; Vera-Lozada G; Hassan R; Niedobitek G
PLoS One; 2015; 10(5):e0124531. PubMed ID: 25978381
[TBL] [Abstract][Full Text] [Related]
15. Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma.
Deau B; Bachy E; Ribrag V; Delarue R; Rubio MT; Bosq J; Varet B; Brousse N; Hermine O; Canioni D
Leuk Lymphoma; 2013 Jan; 54(1):41-5. PubMed ID: 22667341
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role and correlation of CA9, CD31, CD68 and CD20 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.
Diana A; Wang LM; D'Costa Z; Azad A; Silva MA; Soonawalla Z; Allen P; Liu S; McKenna WG; Muschel RJ; Fokas E
Oncotarget; 2016 Nov; 7(45):72819-72832. PubMed ID: 27637082
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic significance of CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's Lymphoma].
Fu XH; Wang SS; Huang Y; Xiao J; Zhai LZ; Xia ZJ; Huang HQ; Sun XF; Lin TY
Ai Zheng; 2008 Nov; 27(11):1197-203. PubMed ID: 19000453
[TBL] [Abstract][Full Text] [Related]
18. Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma.
Gotti M; Nicola M; Lucioni M; Fiaccadori V; Ferretti V; Sciarra R; Costanza M; Bono E; Molo S; Maffi A; Croci GA; Varettoni M; Frigeni M; Pascutto C; Arcaini L; Bonfichi M; Paulli M; Cazzola M
Hematol Oncol; 2017 Sep; 35(3):296-302. PubMed ID: 27060262
[TBL] [Abstract][Full Text] [Related]
19. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.
Azambuja D; Natkunam Y; Biasoli I; Lossos IS; Anderson MW; Morais JC; Spector N
Ann Oncol; 2012 Mar; 23(3):736-742. PubMed ID: 21602260
[TBL] [Abstract][Full Text] [Related]
20. The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma.
Jakovic LR; Mihaljevic BS; Perunicic Jovanovic MD; Bogdanovic AD; Andjelic BM; Bumbasirevic VZ
Leuk Lymphoma; 2011 Oct; 52(10):1913-9. PubMed ID: 21663512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]